ArchOTC Deep Dive: Is It the Best OTC Platform for U.S. Investors in 2026?
We spent 30 days evaluating ArchOTC's platform โ testing execution speed, compliance documentation, account tier structure, and customer support. Our conclusion: it's the most well-rounded SEC-registered OTC platform currently available.
Key findings: The Starter tier ($1Kโ$5K) offers 2X leverage and 3% weekly ROI targets โ exceptionally accessible for new OTC investors. The Elite and Institutional tiers scale up to 10X leverage and 15% weekly targets, backed by dedicated portfolio managers.